Author details

Full Name

Stephanie Fischinger

Affiliation

ORCID

Career Start Year

2018

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36781879	Robust induction of functional humoral response by a plant-derived Coronavirus-like particle vaccine candidate for COVID-19.		2023
37469133	A Single-Dose Intranasal Combination Panebolavirus Vaccine.		2023
37322179	ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19.	Nat Immunol	2023
37252360	Lectin Fingerprinting Distinguishes Antibody Neutralization in SARS-CoV-2.	ACS Cent Sci	2023
37379655	IFN-Î³ independent markers of Mycobacterium tuberculosis exposure among male South African gold miners.	EBioMedicine	2023
37056371	Diagnostic TR-FRET assays for detection of antibodies in patient samples.	Cell Rep Methods	2023
35348368	mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions.	Sci Transl Med	2022
35762593	The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia.	mBio	2022
35879311	A single immunization with a modified vaccinia Ankara vectored vaccine producing Sudan virus-like particles protects from lethal infection.	npj Vaccines	2022
36000735	Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.	mBio	2022
35413078	Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center.	PLoS ONE	2022
35413022	Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV.	J Acquir Immune Defic Syndr	2022
35357886	A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection.	Sci Immunol	2022
35213690	Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence in Massachusetts Estimated from Newborn Screening Specimens.	Clin Infect Dis	2022
35143473	SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort.	PLoS Biology	2022
35090580	mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern.	Immunity	2022
35073738	Serological Markers of SARS-CoV-2 Reinfection.	mBio	2022
35073571	Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study.	Blood Adv	2022
34652962	Early cross-coronavirus reactive signatures of humoral immunity against COVID-19.	Sci Immunol	2021
33589825	Humoral signatures of protective and pathological SARS-CoV-2 infection in children.	Nat Med	2021
33589636	Discrete SARS-CoV-2 antibody titers track with functional humoral stability.	Nat Commun	2021
34013263	Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19.	bioRxiv	2021
34117252	SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung.	Nat Commun	2021
33688652	Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates.		2021
33631118	A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs.	Immunity	2021
33476549	Compromised SARS-CoV-2-specific placental antibody transfer.	Cell	2021
33469218	Publisher Correction: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.	Nature	2021
33621211	Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2.	JCI Insight	2021
33674572	Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques.	Nat Commun	2021
34196711	Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2.	J Appl Lab Med	2021
33873199	Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.	Nature	2021
33504598	Production of HIV-1 Env-specific antibodies mediating innate immune functions depends on cognate IL-21- secreting CD4+ T cells.	J Virol	2021
33821279	Sexually dimorphic placental responses to maternal SARS-CoV-2 infection.	bioRxiv	2021
34315825	Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates.	Science Translational Medicine	2021
33594366	Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates.	bioRxiv	2021
33427208	Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022.	JCI Insight	2021
34630406	A <i>Mycobacterium tuberculosis</i> Specific IgG3 Signature of Recurrent Tuberculosis.	Front Immunol	2021
34664987	Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responses.	Sci Transl Med	2021
34843602	Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials.	PLoS Pathog	2021
34553511	Liver Fibrosis Index FIB-4 Is Associated With Mortality in COVID-19.	Hepatology Communications	2021
34494026	Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profiles.	bioRxiv	2021
32554928	Protein-based, but not viral vector alone, HIV vaccine boosting drives an IgG1-biased polyfunctional humoral immune response.	JCI insight	2020
32434946	SARS-CoV-2 infection protects against rechallenge in rhesus macaques.	Science	2020
32434945	DNA vaccine protection against SARS-CoV-2 in rhesus macaques.	Science	2020
32884153	Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters.	Nat Med	2020
32827525	Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses.	J Pediatr	2020
33207184	Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality.	Cell	2020
33038764	An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South Africa.	EBioMedicine	2020
32878931	Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity.	mSphere	2020
33200139	Epidemiological and immunological features of obesity and SARS-CoV-2.	medRxiv	2020